The results of a recent meta-analysis have demonstrated that levels of CCL2, CCL5, CCL11, and CX3CL1 chemokines were significantly higher in people with T2D than in the control participants [13]. The gene discussed is CCL2; the disease is type 2 diabetes mellitus.